Gavrilov I. Pharmacotherapeutic efficiency of corvitinum in conditions of crush-syndrome

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0413U004526

Applicant for

Specialization

  • 14.03.05 - Фармакологія

14-06-2013

Specialized Academic Board

Д 41.600.01

Odessa National Medical University

Essay

Dissertation is devoted to research of treatment-and-prophylactic efficiency of bioflavonoidcontaining drug corvitinum on crush-syndrome model. Pharmacotherapeutic efficiency of corvitinum realizes in its ability to support protective-compensatory mechanisms, directed on diminishing of hyperproduction of endo¬genous toxins degree, also in discontinuation of free-radical chain reactions, correction of imbalance in energy metabolism, prevention of oxidation and phosphorylation processes uncoupling and maintenance of the detoxicative system functioning in conditions of crush-syndrome. Moreover, corvitinum corrects the level of high-specific marker of rhabdomyolisis – myoglobin – and compensates metabolic acidosis which develops in this case, by normalization of the oxygen mode and maintenance of the main buffer systems of blood plasma.

Files

Similar theses